NCT06908629 Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
| NCT ID | NCT06908629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barbara Ann Karmanos Cancer Institute |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-09-03 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-09-03 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside in Metro Detroit, Michigan. Main questions to answer are: * Can we have a completion rate of at least 80% of participants filling out the screening tool? * Can we determine procedures for patient referrals based on social needs * Can we implement brief interventions based on food access and digital inclusion (ensuring everyone has access to the digital technologies they need to participate in society)
Eligibility Criteria
Inclusion Criteria: * 18 years or older * past or current cancer diagnosis * reside in metropolitan Detroit (Wayne, Oakland, Macomb counties) * English proficient * Actively receiving care through one of Karmano's Cancer Institute's outpatient clinics OR post treatment survivors in the Detroit Research on Cancer Survivors (ROCS) longitudinal cohort study who have reported past food insecurity and agreed to be contacted for further research Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06908629 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06908629 currently recruiting?
Yes, NCT06908629 is actively recruiting participants. Contact the research team at hayley.thompson@wayne.edu for enrollment information.
Where is the NCT06908629 trial being conducted?
This trial is being conducted at Detroit, United States.
Who is sponsoring the NCT06908629 clinical trial?
NCT06908629 is sponsored by Barbara Ann Karmanos Cancer Institute. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.